Please login to the form below

Not currently logged in
Email:
Password:

Anthim

This page shows the latest Anthim news and features for those working in and with pharma, biotech and healthcare.

FDA approves new drugs from Teva, Lilly and Elusys

FDA approves new drugs from Teva, Lilly and Elusys

Cinqair, Taltz and Anthim have all been given the green light in the US. ... Finally, the FDA has also approved Elusys' Anthim (obiltoxaximab), an injectable treatment for anthrax infections caused by breathing in the bacterium Bacillus anthracis.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics